Effectiveness of Paxlovid in the treatment of the SARS-CoV-2 Omicron variant infection in children with hematologic malignancies: a retrospective cohort study
Administering Paxlovid within 5 days of the diagnosis of the SARS-CoV-2 Omicron variant infection in children may effectively shorten the clearance time of the virus, but there is still the possibility the patients may have re-positive test results.
Authors
- Yuelian Jiang
- Qing Cao (ORCID: https://orcid.org/0000-0001-9230-4076)
- Jing Chen (ORCID: https://orcid.org/0000-0001-6914-6233)
- Wenjuan Chen (ORCID: https://orcid.org/0000-0002-9262-5600)
- Hao Li
- Xiaoxia Deng
- Xia Qin
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Children's Medical Center (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2024-08-01
- DOI
- https://doi.org/10.21037/tcr-24-70
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39